Prevalidation of a human cornea construct as an alternative to animal corneas for in vitro drug absorption studies.

Standard

Prevalidation of a human cornea construct as an alternative to animal corneas for in vitro drug absorption studies. / Hahne, Matthias; Zorn-Kruppa, Michaela; Guzman, Gustavo; Brandner, Johanna; Haltner-Ukomado, Eleonore; Wätzig, Hermann; Reichl, Stephan.

In: J PHARM SCI-US, Vol. 101, No. 8, 8, 2012, p. 2976-2988.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Hahne M, Zorn-Kruppa M, Guzman G, Brandner J, Haltner-Ukomado E, Wätzig H et al. Prevalidation of a human cornea construct as an alternative to animal corneas for in vitro drug absorption studies. J PHARM SCI-US. 2012;101(8):2976-2988. 8.

Bibtex

@article{e185762c65b1417b88b03ecf99eb76d1,
title = "Prevalidation of a human cornea construct as an alternative to animal corneas for in vitro drug absorption studies.",
abstract = "The use of ophthalmic drugs has increased consistently over the past few decades. Currently, most research is conducted using in vivo and ex vivo animal experiments; however, they have many disadvantages, including ethical concerns, high costs, the questionable extension of animal results to humans, and poor standardization. Although several cell culture-based cornea models have been developed, none have been validated and accepted for general use. In this study, a standardized, three-dimensional model of the human cornea (Hemicornea, HC) based on immortalized human corneal cells and cultivated in serum-free conditions was developed for drug absorption studies and prevalidated using compounds with a wide range of molecular characteristics (sodium fluorescein, rhodamine B, fluorescein isothiocyanate-labeled dextran, aciclovir, bimatoprost, dexamethasone, and timolol maleate). The HC model was independently cultured in three different laboratories, and the intralaboratory and interlaboratory reproducibility was analyzed and compared with the rabbit cornea. This analysis showed that the HC has a barrier in the same range as excised animal corneas, although with a higher reproducibility and lower variability. Because of the demonstrated transferability, the HC represents a promising in vitro alternative to the use of ex vivo tissue and offers a well-defined and standardized system for drug absorption studies.",
keywords = "Animals, Humans, Female, Rabbits, Cell Line, Swine, Cell Culture Techniques, Administration, Ophthalmic, Epithelium, Corneal/*cytology/*metabolism/ultrastructure, Ophthalmic Solutions/*administration & dosage, Pharmaceutical Preparations/*administration & dosage, Pharmacokinetics, Animals, Humans, Female, Rabbits, Cell Line, Swine, Cell Culture Techniques, Administration, Ophthalmic, Epithelium, Corneal/*cytology/*metabolism/ultrastructure, Ophthalmic Solutions/*administration & dosage, Pharmaceutical Preparations/*administration & dosage, Pharmacokinetics",
author = "Matthias Hahne and Michaela Zorn-Kruppa and Gustavo Guzman and Johanna Brandner and Eleonore Haltner-Ukomado and Hermann W{\"a}tzig and Stephan Reichl",
year = "2012",
language = "English",
volume = "101",
pages = "2976--2988",
journal = "J PHARM SCI-US",
issn = "0022-3549",
publisher = "John Wiley and Sons Inc.",
number = "8",

}

RIS

TY - JOUR

T1 - Prevalidation of a human cornea construct as an alternative to animal corneas for in vitro drug absorption studies.

AU - Hahne, Matthias

AU - Zorn-Kruppa, Michaela

AU - Guzman, Gustavo

AU - Brandner, Johanna

AU - Haltner-Ukomado, Eleonore

AU - Wätzig, Hermann

AU - Reichl, Stephan

PY - 2012

Y1 - 2012

N2 - The use of ophthalmic drugs has increased consistently over the past few decades. Currently, most research is conducted using in vivo and ex vivo animal experiments; however, they have many disadvantages, including ethical concerns, high costs, the questionable extension of animal results to humans, and poor standardization. Although several cell culture-based cornea models have been developed, none have been validated and accepted for general use. In this study, a standardized, three-dimensional model of the human cornea (Hemicornea, HC) based on immortalized human corneal cells and cultivated in serum-free conditions was developed for drug absorption studies and prevalidated using compounds with a wide range of molecular characteristics (sodium fluorescein, rhodamine B, fluorescein isothiocyanate-labeled dextran, aciclovir, bimatoprost, dexamethasone, and timolol maleate). The HC model was independently cultured in three different laboratories, and the intralaboratory and interlaboratory reproducibility was analyzed and compared with the rabbit cornea. This analysis showed that the HC has a barrier in the same range as excised animal corneas, although with a higher reproducibility and lower variability. Because of the demonstrated transferability, the HC represents a promising in vitro alternative to the use of ex vivo tissue and offers a well-defined and standardized system for drug absorption studies.

AB - The use of ophthalmic drugs has increased consistently over the past few decades. Currently, most research is conducted using in vivo and ex vivo animal experiments; however, they have many disadvantages, including ethical concerns, high costs, the questionable extension of animal results to humans, and poor standardization. Although several cell culture-based cornea models have been developed, none have been validated and accepted for general use. In this study, a standardized, three-dimensional model of the human cornea (Hemicornea, HC) based on immortalized human corneal cells and cultivated in serum-free conditions was developed for drug absorption studies and prevalidated using compounds with a wide range of molecular characteristics (sodium fluorescein, rhodamine B, fluorescein isothiocyanate-labeled dextran, aciclovir, bimatoprost, dexamethasone, and timolol maleate). The HC model was independently cultured in three different laboratories, and the intralaboratory and interlaboratory reproducibility was analyzed and compared with the rabbit cornea. This analysis showed that the HC has a barrier in the same range as excised animal corneas, although with a higher reproducibility and lower variability. Because of the demonstrated transferability, the HC represents a promising in vitro alternative to the use of ex vivo tissue and offers a well-defined and standardized system for drug absorption studies.

KW - Animals

KW - Humans

KW - Female

KW - Rabbits

KW - Cell Line

KW - Swine

KW - Cell Culture Techniques

KW - Administration, Ophthalmic

KW - Epithelium, Corneal/cytology/metabolism/ultrastructure

KW - Ophthalmic Solutions/administration & dosage

KW - Pharmaceutical Preparations/administration & dosage

KW - Pharmacokinetics

KW - Animals

KW - Humans

KW - Female

KW - Rabbits

KW - Cell Line

KW - Swine

KW - Cell Culture Techniques

KW - Administration, Ophthalmic

KW - Epithelium, Corneal/cytology/metabolism/ultrastructure

KW - Ophthalmic Solutions/administration & dosage

KW - Pharmaceutical Preparations/administration & dosage

KW - Pharmacokinetics

M3 - SCORING: Journal article

VL - 101

SP - 2976

EP - 2988

JO - J PHARM SCI-US

JF - J PHARM SCI-US

SN - 0022-3549

IS - 8

M1 - 8

ER -